Mapping Human Muscle Satellite Cell Fate By Real-Time Imaging
NCT ID: NCT02685319
Last Updated: 2017-06-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
7 participants
INTERVENTIONAL
2016-02-29
2016-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Muscle Force Assessment in the Intensive Care Unit and in Primary Myopathies
NCT00735384
Defining 31Phosphorous Magnetic Resonance Spectroscopy Characteristics in Patients With Mitochondrial Myopathy
NCT01301235
Magnetic Resonance and Optical Imaging of Dystrophic and Damaged Muscle
NCT02168114
Muscle Biopsies in Healthy Volunteers
NCT01431677
Neurophysiological Evaluation of Muscle Tone
NCT05070780
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
muscle biopsy
a muscle sample will be taken from the mid-thigh (Vastus Lateralis) and analyzed
muscle biopsy
a muscle sample will be taken from the mid-thigh (Vastus Lateralis) and analyzed
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
muscle biopsy
a muscle sample will be taken from the mid-thigh (Vastus Lateralis) and analyzed
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI between 20 and 34.9
* Fasting Glucose \<110 mg/dL
* Blood Pressure \<160/100mm Hg
* Non-Diabetic
* LDL-Cholesterol \<160mg/dL
* Triacylglycerol \<400 mg/dL
* Makers of kidney, liver, and heart functions within 10% of clinical normalcy
* \<1.5hr /wk of habitual aerobic exercise training and no resistance exercise training in the past 6 months
Exclusion Criteria
* BMI between \<20 and \>34.9
* Fasting Glucose \>110 mg/dL
* Blood Pressure \>160/100mm Hg
* Non-Diabetic
* LDL-Cholesterol \>160mg/dL
* Triacylglycerol \>400 mg/dL
* Pre-existing kidney or liver conditions
--\>1.5hr /wk of habitual aerobic exercise training and no resistance exercise training in the past 6 months
* Currently taking prescribed blood thinners
20 Years
29 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Purdue University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Wayne Campbell
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Wayne W Campbell, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Purdue University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Purdue University - Stone Hall 700 W State St
West Lafayette, Indiana, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1512016862
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.